{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:35Z","timestamp":1761959315015,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.rmcr.2022.101579","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:27:05Z","timestamp":1641299225000},"page":"101579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A case of PD-L1 negative advanced pulmonary sarcomatoid carcinoma effectively treated with atezolizumab, carboplatin, paclitaxel, and bevacizumab"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-2917","authenticated-orcid":false,"given":"Kosuke","family":"Sawatari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2022.101579_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.surg.2012.05.007","article-title":"Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis","volume":"152","author":"Yendamuri","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.rmcr.2022.101579_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2016.05.013","article-title":"Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages","volume":"98","author":"Vieira","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.rmcr.2022.101579_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.01.014","article-title":"Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma","volume":"15","author":"Domblides","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.rmcr.2022.101579_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10147-019-01431-z","article-title":"The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV","volume":"24","author":"Akamatsu","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.rmcr.2022.101579_bib5","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/01.JTO.0000437008.00554.90","article-title":"Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma","volume":"8","author":"Vieira","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.rmcr.2022.101579_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13019-019-0991-y","article-title":"Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report","volume":"14","author":"Qin","year":"2019","journal-title":"J. Cardiothorac. Surg."},{"key":"10.1016\/j.rmcr.2022.101579_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1066896908330049","article-title":"Review article: pulmonary sarcomatoid carcinomas: a practical overview","volume":"18","author":"Pelosi","year":"2010","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.rmcr.2022.101579_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2016.12.010","article-title":"\u201cSarcomatoid\u201d carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification","volume":"63","author":"Weissferdt","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.rmcr.2022.101579_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humpath.2013.09.005","article-title":"Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin","volume":"45","author":"Terra","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.rmcr.2022.101579_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691186","article-title":"Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy","volume":"39","author":"Fiala","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.rmcr.2022.101579_bib11","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1200\/JCO.2012.47.9626","volume":"31","author":"Patel","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.rmcr.2022.101579_bib12","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2022.101579_bib13","first-page":"3331","article-title":"Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lung","volume":"32","author":"Tsubata","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.rmcr.2022.101579_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:04:48Z","timestamp":1761959088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007122000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":14,"alternative-id":["S2213007122000016"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101579","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of PD-L1 negative advanced pulmonary sarcomatoid carcinoma effectively treated with atezolizumab, carboplatin, paclitaxel, and bevacizumab","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101579"}}